Skip to content

Study comparing two different combination of drugs for preventing vomiting after surgery.

Efficacy of combining midazolam vs dexamethasone with ondansetron for prevention of Postoperative Nausea and Vomiting among women undergoing emetogenic surgeries - A randomised control trial

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2021/04/032750
Enrollment
124
Registered
2021-04-12
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: O- Medical and Surgical

Interventions

Intervention1: MIDAZOLAM: This group will receive single dose of 0.04 mg/kg IV of Inj. Midazolam after induction .30 minutes prior to extubation,single dose of Inj. Ondansetron 0.1mg/kg IV will be gi

Sponsors

Bangalore Baptist hospital
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Laparoscopic surgeries Middle ear surgeries Gynaecological surgeries Breast surgeries Cholecystecomies BMI

Exclusion criteria

Exclusion criteria: Smokers Pregnant/lactating women Use of nitrous oxide intraoperatively Patients having history of motion sickness/ PONV Patients on chronic steroid therapy Patients on chronic opiod analgesics Patients on preoperative chemotherapy Patients who receive antiemetic/steroid 24 hrs prior to commencement of study Patients suffering from diabetes mellitus with autonomic neuropathy, intestinal obstruction, hiatus hernia, hepatic and renal diseases Patients with neurological diseases/ Neuromuscular diseases Patients with prolonged QTC interval Patients on CNS depressant drugs Patients with psychiatric illness or cognitive impairment

Design outcomes

Primary

MeasureTime frame
To compare the effectiveness of Midazolam and Ondansetron Vs Dexamethasone and Ondansetron in prophylaxis of Post operative Nausea Vomiting in female patients undergoing emetogenic surgeries.Timepoint: 24 hrs

Secondary

MeasureTime frame
1.Total dose of rescue antiemetic required 2.Total episodes of Nausea and Vomiting 3.Sedation score postoperativelyTimepoint: 1hr , 6hr , 12 hr

Countries

India

Contacts

Public ContactDr Yashaswini H Raya

Bangalore Baptist Hospital

drpriyagdoc@gmail.com9886031472

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026